This proposal first aims to improve, develop, and test powerful new molecular techniques to monitor and manipulate dynamic signal transduction in neurons. Goals for voltage indicators based on photoinduced electron transfer include greater sensitivity, genetic targeting, and longer wavelengths. New far-red fluorescent proteins engineered from phycobiliproteins are promising building blocks for in vivo indicators of cell cycle status, Ca2+, and protease activity. A novel alternative approach to measuring and manipulating neuronal activity is to engineer an artificial transcription factor activated by simultaneous high [Ca2+] and illumination, greatly improving on endogenous activity reporters such as c-fos. The genetically encoded "snapshot reporter" will capture the pattern of activity throughout a large ensemble of neurons at a time precisely defined by the triggering illumination, then drive expression of effector genes to mark those cells and allow selective excitation, inhibition, or ablation to test their functional importance. A chimeric channelrhodopsin activatable by red light permits optogenetic excitation of deep neurons through the intact skull, but its peak wavelength should be further increased and its residual sensitivity to blue light suppressed. Optogenetic inhibition of synaptic release will be improved by a more efficient singlet-oxygen generating protein, and introducing a singlet- oxygen-sensing GFP to map the spatial extent of inhibition. Both optogenetic tools will be applied to dissect amygdalar circuits in fear conditioning. The singlet-oxygen generating protein can now be split into two complementary fragments that only become photoactive after being brought together by chimeric partners. This complementation system may allow protein-protein interactions and kinase and protease activity to be captured for subsequent visualization by electron microscopy. A genetically encoded tag that marks proteins made during a pharmacologically defined period may become applicable to image synthesis and degradation of proteins in intact brain, thanks to development of nanoparticles that deliver small molecule drugs across the blood-brain barrier. Such nanoparticles may also aid clinical drug delivery to the brain. Such techniques will be used to test a new hypothesis that very long-term memories such as fear conditioning are stored as the pattern of holes in the perineuronal net (PNN), a specialized extracellular matrix that envelops mature neurons and restricts synapse formation. The 3-D intertwining of PNN and synapses will be imaged by serial-section electron microscopy. Lifetimes of PNN vs. intrasynaptic components will be compared by pulse-chase 15N labeling in mice and 14C content in human cadaver brains. Genetically encoded indicators and anti-neoepitope antibodies should improve spatial and temporal resolution of the in vivo activity of proteases that locally erode PNN. New techniques including genetic knockouts, better pharmacological inhibitors, and the snapshot reporter should enable more precise inhibition or potentiation of PNN erosion to compare with behavioral consequences. Biosynthesis of PNN components and proteases will be imaged.

Public Health Relevance

This proposal aims to improve, develop, and test powerful new molecular techniques to monitor and manipulate dynamic signal transduction in neurons. Such techniques will be used to test a new hypothesis, that very long-term memories are stored in the pattern of holes in the perineuronal net, a coating that envelops mature neurons and synapses. Both aims would profoundly advance our understanding of how neurons encode and store information, with potential implications for ameliorating addiction, traumatic brain injury, and neurodegeneration.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS027177-26
Application #
8630741
Study Section
Biophysics of Neural Systems Study Section (BPNS)
Program Officer
Talley, Edmund M
Project Start
1989-09-01
Project End
2017-12-31
Budget Start
2014-01-01
Budget End
2014-12-31
Support Year
26
Fiscal Year
2014
Total Cost
$630,151
Indirect Cost
$218,475
Name
University of California San Diego
Department
Pharmacology
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Nabavi, Sadegh; Fox, Rocky; Proulx, Christophe D et al. (2014) Engineering a memory with LTD and LTP. Nature 511:348-52
Davalos, Dimitrios; Baeten, Kim M; Whitney, Michael A et al. (2014) Early detection of thrombin activity in neuroinflammatory disease. Ann Neurol 75:303-8
Inagaki, Hidehiko K; Jung, Yonil; Hoopfer, Eric D et al. (2014) Optogenetic control of Drosophila using a red-shifted channelrhodopsin reveals experience-dependent influences on courtship. Nat Methods 11:325-32
Lin, John Y; Sann, Sharon B; Zhou, Keming et al. (2013) Optogenetic inhibition of synaptic release with chromophore-assisted light inactivation (CALI). Neuron 79:241-53
Lin, John Y (2013) Production and validation of recombinant adeno-associated virus for channelrhodopsin expression in neurons. Methods Mol Biol 998:401-15
Tsien, Roger Y (2013) Very long-term memories may be stored in the pattern of holes in the perineuronal net. Proc Natl Acad Sci U S A 110:12456-61
Lin, John Y; Knutsen, Per Magne; Muller, Arnaud et al. (2013) ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat Neurosci 16:1499-508
Whitney, Michael A; Crisp, Jessica L; Nguyen, Linda T et al. (2011) Fluorescent peptides highlight peripheral nerves during surgery in mice. Nat Biotechnol 29:352-6
Lin, John Y (2011) A user's guide to channelrhodopsin variants: features, limitations and future developments. Exp Physiol 96:19-25
Shaner, Nathan C; Lin, Michael Z; McKeown, Michael R et al. (2008) Improving the photostability of bright monomeric orange and red fluorescent proteins. Nat Methods 5:545-51

Showing the most recent 10 out of 107 publications